This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dahia, P. L. M. Articles by Grossman, A. B. Search for Related Content PubMed PubMed Citation Articles by Dahia, P. L. M. Articles by Grossman, A. B.

Expression of Glucocorticoid Receptor Gene Isoforms in Corticotropin-Secreting Tumors¹

Department of Endocrinology (P.L.M.D., A.M., R.A.J., S.L.C., G.M.B., A.B.G.), St. Bartholomew’s Hospital, London EC1A 7BE, United Kingdom; Neurochirurgische Klinik der Universität Erlangen-Nürnberg (J.H., R.F.), 91054 Erlangen, Germany; and Klinikum der Bayerischen Julius-Maximilians-Universität Würzburg (M.R), D-97080 Würzburg, Germany

Address all correspondence and requests for reprints to: Prof. Ashley Grossman, Department of Endocrinology, St. Bartholomew’s Hospital, London EC1A 7BE, United Kingdom. E-mail: a.b.grossman{at}mds.qmw.ac.uk

The molecular basis of Cushing’s disease is not known. One of the most characteristic features of such tumors is their resistance to corticosteroid feedback at the pituitary level. We have hypothesized that abnormalities of the glucocorticoid receptor (GR) gene might play a role in the development of Cushing’s disease via an increase in the relative production of the nonligand-binding splice variant of the GR, GRß, known to exert dominant negative effects over the ligand-binding isoform, GR. Alternatively, a change in overall GR expression, or mutations of some functional domains of the GR gene, might be involved in the pathogenesis of corticotroph tumors.

We studied 22 tumors (17 pituitary ACTH-secreting tumors, 2 ectopic ACTH-producing tumors, 2 prolactinomas, and 1 nonfunctioning adenoma) and three normal pituitaries. RT-PCR was performed with primers specific to GR and GRß complementary DNA, followed by Southern blotting using an internal probe, and the ratio of the two bands quantitated by densitometry. We also assessed the overall expression of GR relative to the message of both the POMC gene and a housekeeping gene. Single-strand conformation polymorphism analysis of the DNA-binding domain and splice junction region of the gene was also performed.

GR messenger RNA was expressed at 37.3-fold ± 5.7 (range, 32 to 46) excess, as compared with the GRß subform. This pattern was observed both in the tumor samples and in the normal pituitaries used as controls. A majority of the ACTH-secreting tumors (16/19), including the ectopic secretors, showed variable but increased overall GR expression, whereas 3 tumors showed an expression approximately equivalent to the normal controls; however, no correlation was found between these two groups and the response to the high-dose dexamethasone test, nor was there any correlation with tumor histology. No mutations were found in any of the tumors by PCR-single-strand conformation polymorphism analysis.

In conclusion, although both pituitary and ectopic ACTH-secreting tumors are at least partially glucocorticoid-resistant, no significant abnormalities in the relative expression of the two main GR subforms were observed in a series of such tumors. Additionally, mutations of regions critical to normal function of the receptor do not seem to be a frequent event in these tumors.

This article has been cited by other articles:

				M. J. M. Schaaf, D. Champagne, I. H. C. van Laanen, D. C. W. A. van Wijk, A. H. Meijer, O. C. Meijer, H. P. Spaink, and M. K. Richardson Discovery of a Functional Glucocorticoid Receptor {beta}-Isoform in Zebrafish Endocrinology, April 1, 2008; 149(4): 1591 - 1599. [Abstract] [Full Text] [PDF]

				T. Nigawara, Y. Iwasaki, M. Asai, M. Yoshida, M. Kambayashi, H. Sashinami, K. Hashimoto, and T. Suda Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Eliminates Impaired Glucocorticoid Suppression and Induces Apoptosis in Corticotroph Tumor Cells Endocrinology, February 1, 2006; 147(2): 769 - 772. [Abstract] [Full Text] [PDF]

				M Messager, C Carriere, X Bertagna, and Y de Keyzer RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome Eur. J. Endocrinol., January 1, 2006; 154(1): 159 - 166. [Abstract] [Full Text] [PDF]

				Y. S. Woo, A. M. Isidori, W. Z. Wat, G. A. Kaltsas, F. Afshar, I. Sabin, P. J. Jenkins, J. P. Monson, G. M. Besser, and A. B. Grossman Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting Macroadenomas J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4963 - 4969. [Abstract] [Full Text] [PDF]

				M. T. Rae, D. Niven, H. O. D. Critchley, C. R. Harlow, and S. G. Hillier Antiinflammatory Steroid Action in Human Ovarian Surface Epithelial Cells J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4538 - 4544. [Abstract] [Full Text] [PDF]

				D. G. Morris, B. Kola, N. Borboli, G. A. Kaltsas, M. Gueorguiev, A. M. McNicol, R. Ferrier, T. H. Jones, S. Baldeweg, M. Powell, et al. Identification of Adrenocorticotropin Receptor Messenger Ribonucleic Acid in the Human Pituitary and Its Loss of Expression in Pituitary Adenomas J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6080 - 6087. [Abstract] [Full Text] [PDF]

				A. Lania, G. Mantovani, and A. Spada Genetics of Pituitary Tumors: Focus on G-Protein Mutations Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017. [Abstract] [Full Text] [PDF]

				R. C.Y. Lin, X. L. Wang, and B. J. Morris Association of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant Hypertension, March 1, 2003; 41(3): 404 - 407. [Abstract] [Full Text] [PDF]

				L. Pujols, J. Mullol, J. Roca-Ferrer, A. Torrego, A. Xaubet, J. A. Cidlowski, and C. Picado Expression of glucocorticoid receptor alpha - and beta -isoforms in human cells and tissues Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1324 - C1331. [Abstract] [Full Text] [PDF]

				M. Korbonits, H. S. Chahal, G. Kaltsas, S. Jordan, Y. Urmanova, Z. Khalimova, P. E. Harris, W. E. Farrell, F.-X. Claret, and A. B. Grossman Expression of Phosphorylated p27Kip1 Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2635 - 2643. [Abstract] [Full Text] [PDF]

				M. Korbonits, I. Bujalska, M. Shimojo, J. Nobes, S. Jordan, A. B. Grossman, and P. M. Stewart Expression of 11{beta}-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2728 - 2733. [Abstract] [Full Text] [PDF]

				B. Kleine, S. Wolfahrt, M. Lotsch, T. Gantner, and W. G. Rossmanith Expression of galanin in human placenta Mol. Hum. Reprod., April 1, 2001; 7(4): 379 - 385. [Abstract] [Full Text] [PDF]

				S. Wolfahrt, B. Kleine, H. Jarry, and W. G. Rossmanith Endogenous regulation of the GnRH receptor by GnRH in the human placenta Mol. Hum. Reprod., January 1, 2001; 7(1): 89 - 95. [Abstract] [Full Text] [PDF]

				L. Pujols, J. Mullol, M. Pérez, J. Roca-Ferrer, M. Juan, A. Xaubet, J. A. Cidlowski, and C. Picado Expression of the Human Glucocorticoid Receptor {alpha} and {beta} Isoforms in Human Respiratory Epithelial Cells and Their Regulation by Dexamethasone Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 49 - 57. [Abstract] [Full Text]

				R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension Hypertension, December 1, 1999; 34(6): 1186 - 1192. [Abstract] [Full Text] [PDF]

				R. H. Oakley, C. M. Jewell, M. R. Yudt, D. M. Bofetiado, and J. A. Cidlowski The Dominant Negative Activity of the Human Glucocorticoid Receptor beta Isoform. SPECIFICITY AND MECHANISMS OF ACTION J. Biol. Chem., September 24, 1999; 274(39): 27857 - 27866. [Abstract] [Full Text] [PDF]

				W. G. Rossmanith, U. Hoffmeister, S. Wolfahrt, B. Kleine, M. McLean, R. A. Jacobs, and A. B. Grossman Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta Mol. Hum. Reprod., May 1, 1999; 5(5): 487 - 494. [Abstract] [Full Text] [PDF]

				P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]

				N. A. T. M. Huizenga, P. de Lange, J. W. Koper, R. N. Clayton, W. E. Farrell, A. J. van der Lely, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 917 - 921. [Abstract] [Full Text]